메뉴 건너뛰기




Volumn 168, Issue 4, 2013, Pages 3679-3682

Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment - The FinPAC study

Author keywords

Anticoagulation; Bleeding; Hematoma; Pacemaker; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

EID: 84886289826     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.022     Document Type: Article
Times cited : (36)

References (27)
  • 1
    • 33745209036 scopus 로고    scopus 로고
    • Post-operative use of heparin increases morbidity of pacemaker implantation
    • C. Marquie, G. De Geeter, and D. Klug Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 4 2006 283 287
    • (2006) Europace , vol.8 , Issue.4 , pp. 283-287
    • Marquie, C.1    De Geeter, G.2    Klug, D.3
  • 2
    • 1542610717 scopus 로고    scopus 로고
    • Pacemaker and implantable cardioverter-defibrillator implantation without reversal of warfarin therapy
    • M.C. Giudici, D.L. Paul, P. Bontu, and S.S. Barold Pacemaker and implantable cardioverter-defibrillator implantation without reversal of warfarin therapy Pacing Clin Electrophysiol 27 3 2004 358 360
    • (2004) Pacing Clin Electrophysiol , vol.27 , Issue.3 , pp. 358-360
    • Giudici, M.C.1    Paul, D.L.2    Bontu, P.3    Barold, S.S.4
  • 3
    • 46049099373 scopus 로고    scopus 로고
    • The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)
    • J.D. Douketis, P.B. Berger, and A.S. Dunn The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 6 Suppl. 2008 299S 339S
    • (2008) Chest , vol.133 , Issue.6 SUPPL.
    • Douketis, J.D.1    Berger, P.B.2    Dunn, A.S.3
  • 4
    • 84856804836 scopus 로고    scopus 로고
    • Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • J.D. Douketis, A.C. Spyropoulos, and F.A. Spencer Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 Suppl. 2012 e326S e350S
    • (2012) Chest , vol.141 , Issue.2 SUPPL.
    • Douketis, J.D.1    Spyropoulos, A.C.2    Spencer, F.A.3
  • 5
    • 0031719955 scopus 로고    scopus 로고
    • Outpatient pacemaker procedures in orally anticoagulated patients
    • D.J. Goldstein, W. Losquadro, and H.M. Spotnitz Outpatient pacemaker procedures in orally anticoagulated patients Pacing Clin Electrophysiol 21 9 1998 1730 1734
    • (1998) Pacing Clin Electrophysiol , vol.21 , Issue.9 , pp. 1730-1734
    • Goldstein, D.J.1    Losquadro, W.2    Spotnitz, H.M.3
  • 6
    • 0037250417 scopus 로고    scopus 로고
    • Implantation of pacemakers and implantable cardioverter-defibrillators in orally anticoagulated patients
    • A.S. al-Khadra Implantation of pacemakers and implantable cardioverter-defibrillators in orally anticoagulated patients Pacing Clin Electrophysiol 26 1 Pt 2 2003 511 514
    • (2003) Pacing Clin Electrophysiol , vol.26 , Issue.1 PART 2 , pp. 511-514
    • Al-Khadra, A.S.1
  • 7
    • 67650541562 scopus 로고    scopus 로고
    • Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin
    • A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, and A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin Am Heart J 158 2 2009 252 256
    • (2009) Am Heart J , vol.158 , Issue.2 , pp. 252-256
    • Tischenko, A.1    Gula, L.J.2    Yee, R.3    Klein, G.J.4    Skanes, A.C.5    Krahn, A.D.6
  • 8
    • 77952572898 scopus 로고    scopus 로고
    • Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation
    • I. Ahmed, E. Gertner, and W.B. Nelson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 6 2010 745 749
    • (2010) Heart Rhythm , vol.7 , Issue.6 , pp. 745-749
    • Ahmed, I.1    Gertner, E.2    Nelson, W.B.3
  • 9
    • 84868204325 scopus 로고    scopus 로고
    • Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices
    • H. Ghanbari, W.S. Phard, and H. Al-Ameri Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices Am J Cardiol 110 10 2012 1482 1488
    • (2012) Am J Cardiol , vol.110 , Issue.10 , pp. 1482-1488
    • Ghanbari, H.1    Phard, W.S.2    Al-Ameri, H.3
  • 10
    • 77952217479 scopus 로고    scopus 로고
    • Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation
    • C. Tompkins, A. Cheng, and D. Dalal Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 21 2010 2376 2382
    • (2010) J Am Coll Cardiol , vol.55 , Issue.21 , pp. 2376-2382
    • Tompkins, C.1    Cheng, A.2    Dalal, D.3
  • 11
    • 0034036119 scopus 로고    scopus 로고
    • A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation
    • G.F. Michaud, F. Pelosi, M.D. Noble, B.P. Knight, F. Morady, and S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 7 2000 1915 1918
    • (2000) J Am Coll Cardiol , vol.35 , Issue.7 , pp. 1915-1918
    • Michaud, G.F.1    Pelosi, F.2    Noble, M.D.3    Knight, B.P.4    Morady, F.5    Strickberger, S.A.6
  • 12
    • 68749100861 scopus 로고    scopus 로고
    • Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: Oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
    • J.M. Tolosana, P. Berne, and L. Mont Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 15 2009 1880 1884
    • (2009) Eur Heart J , vol.30 , Issue.15 , pp. 1880-1884
    • Tolosana, J.M.1    Berne, P.2    Mont, L.3
  • 13
    • 45349095265 scopus 로고    scopus 로고
    • Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
    • P. Karjalainen, S. Vikman, and M. Niemelä Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J 29 8 2008 1001 1010
    • (2008) Eur Heart J , vol.29 , Issue.8 , pp. 1001-1010
    • Karjalainen, P.1    Vikman, S.2    Niemelä, M.3
  • 14
    • 80055096547 scopus 로고    scopus 로고
    • Safety of coronary artery bypass surgery during therapeutic oral anticoagulation
    • K.E. Airaksinen, F. Biancari, and P. Karjalainen Safety of coronary artery bypass surgery during therapeutic oral anticoagulation Thromb Res 128 5 2011 435 439
    • (2011) Thromb Res , vol.128 , Issue.5 , pp. 435-439
    • Airaksinen, K.E.1    Biancari, F.2    Karjalainen, P.3
  • 15
    • 77953011912 scopus 로고    scopus 로고
    • Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: A prospective study
    • P. Korkeila, P. Mustonen, and J. Koistinen Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study Europace 12 6 2010 817 824
    • (2010) Europace , vol.12 , Issue.6 , pp. 817-824
    • Korkeila, P.1    Mustonen, P.2    Koistinen, J.3
  • 16
    • 77957699729 scopus 로고    scopus 로고
    • Surgery EAfC-T. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
    • A.J. Camm, P. Kirchhof, and G.Y. Lip Surgery EAfC-T. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
    • (2010) Eur Heart J , vol.31 , Issue.19 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3
  • 17
    • 84866698766 scopus 로고    scopus 로고
    • Periprocedural heparin bridging in patients receiving vitamin K antagonists: Systematic review and meta-analysis of bleeding and thromboembolic rates
    • D. Siegal, J. Yudin, S. Kaatz, J.D. Douketis, W. Lim, and A.C. Spyropoulos Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates Circulation 126 13 2012 1630 1639
    • (2012) Circulation , vol.126 , Issue.13 , pp. 1630-1639
    • Siegal, D.1    Yudin, J.2    Kaatz, S.3    Douketis, J.D.4    Lim, W.5    Spyropoulos, A.C.6
  • 18
    • 79952202650 scopus 로고    scopus 로고
    • How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: To "bridge" or not to "bridge"?
    • K. Airaksinen, A. Schlitt, A. Rubboli, P. Karjalainen, and G. Lip How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"? EuroIntervention 6 4 2010 520 526
    • (2010) EuroIntervention , vol.6 , Issue.4 , pp. 520-526
    • Airaksinen, K.1    Schlitt, A.2    Rubboli, A.3    Karjalainen, P.4    Lip, G.5
  • 19
    • 79955441513 scopus 로고    scopus 로고
    • Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
    • A. Hakalahti, P. Uusimaa, K. Ylitalo, and M.J. Raatikainen Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment Europace 13 5 2011 640 645
    • (2011) Europace , vol.13 , Issue.5 , pp. 640-645
    • Hakalahti, A.1    Uusimaa, P.2    Ylitalo, K.3    Raatikainen, M.J.4
  • 20
    • 84857652113 scopus 로고    scopus 로고
    • Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices
    • O. Cano, B. Muñoz, and D. Tejada Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices Heart Rhythm 9 3 2012 361 367
    • (2012) Heart Rhythm , vol.9 , Issue.3 , pp. 361-367
    • Cano, O.1    Muñoz, B.2    Tejada, D.3
  • 21
    • 81855194797 scopus 로고    scopus 로고
    • Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices
    • P. Korantzopoulos, K.P. Letsas, T. Liu, N. Fragakis, M. Efremidis, and J.A. Goudevenos Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices Europace 13 12 2011 1669 1680
    • (2011) Europace , vol.13 , Issue.12 , pp. 1669-1680
    • Korantzopoulos, P.1    Letsas, K.P.2    Liu, T.3    Fragakis, N.4    Efremidis, M.5    Goudevenos, J.A.6
  • 22
    • 52449134909 scopus 로고    scopus 로고
    • Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: A systematic review and practical management guide
    • E. Jamula, J. Douketis, and S. Schulman Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide J Thromb Haemost 6 10 2008 1615 1621
    • (2008) J Thromb Haemost , vol.6 , Issue.10 , pp. 1615-1621
    • Jamula, E.1    Douketis, J.2    Schulman, S.3
  • 23
    • 79953239765 scopus 로고    scopus 로고
    • Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
    • A. Cheng, S. Nazarian, and J.A. Brinker Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial Heart Rhythm 8 4 2011 536 540
    • (2011) Heart Rhythm , vol.8 , Issue.4 , pp. 536-540
    • Cheng, A.1    Nazarian, S.2    Brinker, J.A.3
  • 24
    • 84861733232 scopus 로고    scopus 로고
    • Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry
    • H. Lahtela, A. Rubboli, and A. Schlitt Heparin bridging vs. uninterrupted oral anticoagulation in patients with Atrial Fibrillation undergoing Coronary Artery Stenting. Results from the AFCAS registry Circ J 76 6 2012 1363 1368
    • (2012) Circ J , vol.76 , Issue.6 , pp. 1363-1368
    • Lahtela, H.1    Rubboli, A.2    Schlitt, A.3
  • 25
    • 0035125405 scopus 로고    scopus 로고
    • Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
    • J. Hirsh, T. Warkentin, and S. Shaughnessy Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 119 1 Suppl. 2001 64S 94S
    • (2001) Chest , vol.119 , Issue.1 SUPPL.
    • Hirsh, J.1    Warkentin, T.2    Shaughnessy, S.3
  • 26
    • 33845323043 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
    • H. White, N. Kleiman, and K. Mahaffey Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial Am Heart J 152 6 2006 1042 1050
    • (2006) Am Heart J , vol.152 , Issue.6 , pp. 1042-1050
    • White, H.1    Kleiman, N.2    Mahaffey, K.3
  • 27
    • 0025326059 scopus 로고
    • Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis
    • R. Hull, G. Raskob, and D. Rosenbloom Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis N Engl J Med 322 18 1990 1260 1264
    • (1990) N Engl J Med , vol.322 , Issue.18 , pp. 1260-1264
    • Hull, R.1    Raskob, G.2    Rosenbloom, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.